Everest Medicines Launches Nefecon in China’s Hainan Boao Pilot Zone as a First-in-Disease Therapy for IgA Nephropathy

SHANGHAI, April 23, 2023 /PRNewswire/ — Everest Medicines (HKEX 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that Nefecon, the first-in-disease…